Biotechnology Industry Organization Schedules Investor Forum, Talks Crowdfunding

Biotechnology Industry OrganizationAs part of the 12th Annual BIO Investor Forum several sessions are being scheduled to discuss the impact of crowdfunding on the biotech industry.  Taking place next week, October 8-9 in San Francisco, two of their roundtables are addressing crowdfunding and the JOBS Act.

The first specific session is entitled, “Crowdfunding in Healthcare & Biotech: Will It Bridge “The Valley of Death”?”  This discussion notes that smaller private companies are constantly searching for capital.  Crowdfunding has already been used to fill this gap for a number of life science companies.

The moderator for this segment is:  Nicholas Franano, MD, Founder, President & CEO, Novita Therapeutics with panelists including:

  • Gregory C. SimonGregory C. Simon, CEO, Poliwogg
  • Hemai Parthasarathy, PhD, Scientific Director, Breakout Labs/Thiel Foundation
  • Deepa Pakianthan, PhD, General Partner Delphi Ventures
  • Andrew Merickel, PhD, Knobbe Martens

The next topic revolving around crowdfunding is a session titled,  The New Road to IPO in the Age of the JOBS Act

The biotech CEOs and industry experts on this panel will provide an in-depth look into the key elements for a successful offering. Topics will include how to engage with the board, investors and the JOBS Act.

The moderator for this panel is: Jeffrey A. Baumel, Partner, Dentons.  Panelists include:

  • Paul J. Hastings, President and CEO, OncoMed Pharmaceuticals
  • Michael Dybbs, PhD, Principal, New Leaf Venture Partners
  • Michael Margolis, RPh, Managing Director, ROTH Capital Partners
  • Steven J. Mento, PhD, President and CEO, Conatus Pharmaceuticals
Sponsored Links by DQ Promote

Send this to a friend